Ondine Biomedical (LON:OBI) Trading Down 1.7% – Time to Sell?

Ondine Biomedical Inc. (LON:OBI)’s stock price was down 1.7% during trading on Wednesday . The company traded as low as C$14.50 and last traded at C$14.50. 39,166 shares were traded during mid-day trading, a decline of 91% from the average session volume of 448,011 shares. The stock had previously closed at C$14.75.

Ondine Biomedical Stock Performance

The company has a debt-to-equity ratio of 11.85, a quick ratio of 8.26 and a current ratio of 1.23. The stock’s 50 day moving average price is C$14.38 and its 200 day moving average price is C$11.43. The company has a market capitalization of C$7.61 billion, a P/E ratio of -2.09 and a beta of 0.32.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.